Cargando…
Utility of TMPRSS4 as a Prognostic Biomarker and Potential Therapeutic Target in Patients with Gastric Cancer
BACKGROUND: Transmembrane serine protease 4 (TMPRSS4) belongs to the family of type II transmembrane serine proteases that are known to be upregulated in many malignant tumors. However, there is a paucity of studies documenting the clinical impact and biological effects of TMPRSS4 on gastric cancer...
Autores principales: | Tazawa, Hirofumi, Suzuki, Takahisa, Saito, Akihisa, Ishikawa, Akira, Komo, Toshiaki, Sada, Haruki, Shimada, Norimitsu, Hadano, Naoto, Onoe, Takashi, Sudo, Takeshi, Shimizu, Yosuke, Kuraoka, Kazuya, Tashiro, Hirotaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821072/ https://www.ncbi.nlm.nih.gov/pubmed/34379296 http://dx.doi.org/10.1007/s11605-021-05101-2 |
Ejemplares similares
-
Laparoscopic resection for a large gastrointestinal stromal tumor (GIST) with diaphragm invasion following preoperative imatinib treatment: A case report
por: Yoshioka, Shoko, et al.
Publicado: (2021) -
Clinical complete response after nivolumab administered as a third-line treatment for unresectable advanced gastric cancer with peritoneal dissemination: A case report
por: Komo, Toshiaki, et al.
Publicado: (2021) -
Gastric adenocarcinoma appearance in leiomyoma: A case report
por: Wada, Kaoru, et al.
Publicado: (2020) -
A Case of Advanced Gastric Cancer with Peritoneal Metastasis Treated Successfully with Nivolumab
por: Tazawa, Hirofumi, et al.
Publicado: (2019) -
Analysis of Acquisition of COVID-2019 Neutralizing Antibodies in Organ Transplant Recipients
por: Akimoto, Shuji, et al.
Publicado: (2023)